Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC
Clinical trial NCT03952325 · TERMINATED
Trial details
- NCT number
- NCT03952325
- Sponsor
- Odonate Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-09
- Primary completion
- 2021-06-23
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.